Published in Br J Cancer on November 14, 2005
Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 3.14
Chromosome 6p amplification and cancer progression. J Clin Pathol (2006) 1.42
The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res (2012) 1.39
A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. Methods Mol Biol (2014) 1.00
Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma. Mod Pathol (2011) 1.00
Molecular pathology of uveal melanoma. Eye (Lond) (2012) 0.94
Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model. Melanoma Res (2012) 0.91
The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into genome-wide signature of preneoplasia associated with cancer progression. BMC Genomics (2006) 0.90
Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases. Trans Am Ophthalmol Soc (2007) 0.88
FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J Cancer Res Clin Oncol (2008) 0.86
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array. Invest Ophthalmol Vis Sci (2012) 0.85
Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma. Br J Ophthalmol (2013) 0.83
Defining ploidy-specific thresholds in array comparative genomic hybridization to improve the sensitivity of detection of single copy alterations in cell lines. J Mol Diagn (2006) 0.83
In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up. Graefes Arch Clin Exp Ophthalmol (2007) 0.82
Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract (2010) 0.80
The impact of selected factors on early diagnosis of multiple primary cancers in patients with uveal melanoma. Contemp Oncol (Pozn) (2013) 0.75
DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer (2003) 4.68
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res (2004) 3.83
Prognostic implications of monosomy 3 in uveal melanoma. Lancet (1996) 3.26
Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res (2004) 2.56
Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res (2003) 2.18
Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer (1997) 1.87
Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia (2003) 1.64
Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res (2003) 1.59
Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci (2001) 1.57
Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci (2003) 1.34
Pathological and prognostic features of uveal melanomas. Can J Ophthalmol (2004) 1.31
Chromosomal instability detected by fluorescence in situ hybridization in surgical specimens of non-small cell lung cancer is associated with poor survival. Clin Cancer Res (2003) 1.20
Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer (2004) 1.18
Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res (1999) 1.18
Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF). Am J Pathol (1998) 1.17
Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet (2000) 1.15
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res (2001) 1.06
Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma. Genes Chromosomes Cancer (1992) 1.05
Comparative genomic hybridization analysis of archival formalin-fixed paraffin-embedded uveal melanomas. Cancer Genet Cytogenet (1996) 0.99
The identification and differential expression of calcium-binding proteins associated with ocular melanoma. Biochim Biophys Acta (1998) 0.99
Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer (2003) 0.98
Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development. Br J Cancer (2003) 0.97
Acquired homozygosity (isodisomy) of chromosome 3 in uveal melanoma. Cancer Genet Cytogenet (1998) 0.96
International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification. Int J Cancer (2005) 0.95
Cytogenetic analysis of posterior uveal melanoma. Cancer Genet Cytogenet (1993) 0.89
Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells. Invest Ophthalmol Vis Sci (2004) 0.89
MDR1 expression is associated with adverse survival in melanoma of the uveal tract. Hum Pathol (1998) 0.88
Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization. Genes Chromosomes Cancer (2001) 0.86
Expression of epidermal growth factor receptor: risk factor in uveal melanoma. Invest Ophthalmol Vis Sci (2000) 0.83
Abnormalities of the transforming growth factor-beta pathway in ocular melanoma. J Pathol (2000) 0.79
Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol (2005) 8.15
Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science (1998) 7.08
Auditing audits: the method of Oxfordshire Medical Audit Advisory Group. BMJ (1991) 6.22
A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol (2001) 4.61
Auditing audits: use and development of the Oxfordshire Medical Audit Advisory Group rating system. BMJ (1994) 3.64
Advancing the science of symptom management. J Adv Nurs (2001) 3.14
Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nat Genet (1998) 2.63
Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM (2003) 2.45
Oculokinetic perimetry: a simple visual field test for use in the community. Br J Ophthalmol (1985) 2.42
Identification of the cystic fibrosis gene. BMJ (1990) 2.34
Interobserver agreement in grading of colorectal cancers-findings from a nationwide web-based survey of histopathologists. Histopathology (2008) 2.32
A systematic review and meta-analysis of familial prostate cancer risk. BJU Int (2003) 2.01
Peutz-Jeghers syndrome. J Med Genet (1997) 2.01
Systematic review of the relationship between family history and lung cancer risk. Br J Cancer (2005) 1.99
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
A randomised controlled trial of empowerment training for Chinese abused pregnant women in Hong Kong. BJOG (2005) 1.72
Genetic predisposition to ocular melanoma. Eye (Lond) (1999) 1.69
Determination of the amounts of the protein synthesis initiation and elongation factors in wheat germ. J Biol Chem (1990) 1.64
Carney complex, Peutz-Jeghers syndrome, Cowden disease, and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations, but not genetic loci. J Clin Endocrinol Metab (1998) 1.63
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Small-bowel ulceration induced by potassium chloride. Br Med J (1965) 1.57
Retinal and epiretinal glia--an immunohistochemical study. Br J Ophthalmol (1984) 1.54
Isolation of enterochelin from the peritoneal washings of guinea pigs lethally infected with Escherichia coli. Infect Immun (1980) 1.46
Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer (2005) 1.46
Tumour necrosis factor in man: clinical and biological observations. Br J Cancer (1987) 1.46
Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet (1997) 1.42
Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet (2001) 1.42
Comparative evaluation of oculokinetic perimetry and conventional perimetry in glaucoma. Br J Ophthalmol (1988) 1.41
Bacteriostatic effect of human milk and bovine colostrum on Escherichia coli: importance of bicarbonate. Infect Immun (1977) 1.40
Student clinical experiences in shelters for battered women. J Nurs Educ (1993) 1.39
Hospital dentistry: publicise emergency options. Br Dent J (2015) 1.39
Exonic STK11 deletions are not a rare cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.39
Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol (1985) 1.38
Assessment of the visual field by anyone, anywhere and at any time. Trans Ophthalmol Soc U K (1985) 1.38
Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology (1989) 1.38
Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study. Br J Ophthalmol (1984) 1.38
Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut (2000) 1.34
Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. Br J Cancer (2003) 1.33
Alterations in tRNAs containing 2-methylthio-N6-(delta2-isopentenyl)-adenosine during growth of enteropathogenic Escherichia coli in the presence of iron-binding proteins. Eur J Biochem (1978) 1.32
Low-energy long-exposure laser therapy in the management of choroidal melanoma. Graefes Arch Clin Exp Ophthalmol (1986) 1.31
Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation (1998) 1.31
Computerised perimetry with moving and steady fixation in children. Eye (Lond) (1993) 1.28
Genetics and the common cancers. Eur J Cancer (2001) 1.27
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis (2003) 1.24
Replication study of SNP associations for colorectal cancer in Hong Kong Chinese. Br J Cancer (2010) 1.24
Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene (2006) 1.24
Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet (1999) 1.20
The role of the peripherin/RDS gene in retinal dystrophies. Acta Anat (Basel) (1998) 1.20
Evidence that the 5'-untranslated leader of mRNA affects the requirement for wheat germ initiation factors 4A, 4F, and 4G. J Biol Chem (1988) 1.18
Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes. Gut (2002) 1.17
N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis. J Natl Cancer Inst (1981) 1.16
Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity. J Virol (1996) 1.15
Alterations in the tRNA's of Escherichia coli recovered from lethally infected animals. Infect Immun (1978) 1.15
Anterior uveal neurilemmoma--a rare neoplasm simulating malignant melanoma. Br J Ophthalmol (1987) 1.13
Repair of degraded duplex DNA from prehistoric samples using Escherichia coli DNA polymerase I and T4 DNA ligase. Nucleic Acids Res (1998) 1.11
Familial chronic lymphocytic leukaemia: a survey and review of published studies. Br J Haematol (2000) 1.11
Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer (2002) 1.08
Local resection versus enucleation in the management of choroidal melanoma. Eye (Lond) (1987) 1.08
Acute posterior multifocal placoid pigment epitheliopathy. A follow up study. Trans Ophthalmol Soc U K (1983) 1.08
Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer (2000) 1.07
Epiretinal membranes in vitro. Trans Ophthalmol Soc U K (1983) 1.07
CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br J Cancer (2008) 1.06
The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. Am J Hum Genet (2001) 1.06
Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer. J Clin Pathol (2001) 1.05
The TERT variant rs2736100 is associated with colorectal cancer risk. Br J Cancer (2012) 1.05
Email triage of new neurological outpatient referrals from general practice. J Neurol Neurosurg Psychiatry (2004) 1.05
Iron-related modification of bacterial transfer RNA. Nucleic Acids Res (1981) 1.04
Genetic predisposition to gastric cancer. QJM (1999) 1.03
Search for inherited susceptibility to radiation-associated meningioma by genomewide SNP linkage disequilibrium mapping. Br J Cancer (2011) 1.03
Biomaterials used in the posterior segment of the eye. Biomaterials (2000) 1.02
Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol (1984) 1.02
Chromosomal imbalances in familial chronic lymphocytic leukaemia: a comparative genomic hybridisation analysis. Leukemia (2002) 1.02
Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia (2005) 1.01
Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers. Bone (2002) 1.01
Age-related cellular proliferation at the vitreoretinal juncture. Eye (Lond) (1987) 1.00
Objective detection of hemifield and quadrantic field defects by visual evoked cortical potentials. Br J Ophthalmol (1996) 1.00
Risk of cancer death in first-degree relatives of patients with hereditary non-polyposis cancer syndrome (Lynch type II): a study of 130 kindreds in the United Kingdom. Br J Surg (1990) 1.00
Clinical evaluation of a multi-fixation campimeter for the detection of glaucomatous visual field loss. Br J Ophthalmol (1993) 0.98
Evaluation of a bicycle helmet giveaway program--Texas, 1995. Pediatrics (1998) 0.98
Posterior non-vascularized proliferative extraretinopathy and peripheral nodular retinal telangiectasis. Trans Ophthalmol Soc U K (1982) 0.98
A retrospective observational study of the relationship between family history and survival from colorectal cancer. Br J Cancer (2013) 0.97
A personal computer-based visual evoked potential stimulus and recording system. Doc Ophthalmol (1994) 0.97
A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22. Br J Cancer (2011) 0.97
CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours. Br J Cancer (2002) 0.97
A changing climate for grassland research. New Phytol (2006) 0.97
Patient attitudes to receiving copies of outpatient clinic letters from the ocular oncologist to the referring ophthalmologist and GP. Eye (Lond) (2005) 0.96
Effects of endocrine therapy on steroid-receptor content of breast cancer. Br J Cancer (1982) 0.96
Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer (2013) 0.96
Molecular pathology of uveal melanoma. Eye (Lond) (2012) 0.94
Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia (2012) 0.94
Reparative epiretinal fibrosis after diabetic vitrectomy. Trans Ophthalmol Soc U K (1985) 0.94
Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin Exp Immunol (1992) 0.94
STK11 status and intussusception risk in Peutz-Jeghers syndrome. J Med Genet (2006) 0.93
Fluorescent BAT-25 and BAT-26 analysis of T cell prolymphocytic leukaemia. Leukemia (1999) 0.93
Case-control, kin-cohort and meta-analyses provide no support for STK15 F31I as a low penetrance colorectal cancer allele. Br J Cancer (2006) 0.93
Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers. Am J Pathol (2001) 0.92
Ciliary body tumours and their management. Trans Ophthalmol Soc U K (1986) 0.92
Engagement of Toll-like receptors by mycoplasmal superantigen: downregulation of TLR2 by MAM/TLR4 interaction. Cell Microbiol (2005) 0.91
N-acetyl transferase-2 and bladder cancer risk: a meta-analysis. Environ Mol Mutagen (2000) 0.91
Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Invest Ophthalmol Vis Sci (2001) 0.91